ClinicalTrials.govpublic full text
Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
attention deficit hyperactivity disorder (adhd), shp465, adhd, hyperactivity, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 979709
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.